a Formulary status subject to change
Mehandru and Merad reviewed the many clinical manifestations of long-haul COVID, including systemic and musculoskeletal manifestations (chronic fatigue and fibromyalgia symptoms), psychiatric symptoms (insomnia, depression, anxiety, neurocognitive deficits), autonomic and cardiovascular, GIS and renal and respiratory manifestations [71]
Conclusions The current study offers insights suggesting that the combined nebulization of unfractionated heparin, N-acetylcysteine, budesonide, and ipratropium bromide in individuals with COVID-19 pneumonia may enhance lung lesion resorption, leading to improved oxygenation and a reduction in systemic inflammation during the diseases acute phase
In keeping with that theme, I'd like to thank the sponsors of today's podcast